REVANCE THERAPEUTICS LTD
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Established
- 2002-01-01
- Employees
- 597
- Market Cap
- $685.5M
- Website
- http://www.revance.com
Phase 2a Study of DaxibotulinumtoxinA-lanm for Injection in Dynamic Forehead Lines and Glabellar Lines
- First Posted Date
- 2024-05-13
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- Revance Therapeutics, Inc.
- Target Recruit Count
- 27
- Registration Number
- NCT06411002
- Locations
- 🇺🇸
Revance, Nashville, Tennessee, United States
Teosyal RHA® Histology and Intradermal Implantation Evaluation Study
- Conditions
- Histology
- Interventions
- Device: RHA® 1, RHA® 2, RHA® 3, and RHA® 4
- First Posted Date
- 2021-04-15
- Last Posted Date
- 2021-12-01
- Lead Sponsor
- Revance Therapeutics, Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT04846530
- Locations
- 🇨🇦
Woodbridge, Ontario Site, Woodbridge, Ontario, Canada
Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Upper Facial Lines
- Conditions
- Upper Facial Lines (Glabellar Lines, Forehead Lines, & Lateral Canthal Lines)
- Interventions
- First Posted Date
- 2020-02-06
- Last Posted Date
- 2023-06-27
- Lead Sponsor
- Revance Therapeutics, Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT04259086
- Locations
- 🇺🇸
Site 1, Manhattan Beach, California, United States
🇺🇸Site 3, San Diego, California, United States
🇺🇸Site 7, Santa Monica, California, United States
Efficacy and Safety of Increasing Doses of DaxibotulinumtoxinA for Injection (DAXI for Injection) in the Treatment of Moderate or Severe Lateral Canthal Lines
- Conditions
- Lateral Canthal Lines
- Interventions
- Biological: DaxibotulinumtoxinA for injection
- First Posted Date
- 2019-04-10
- Last Posted Date
- 2023-06-27
- Lead Sponsor
- Revance Therapeutics, Inc.
- Target Recruit Count
- 63
- Registration Number
- NCT03911102
- Locations
- 🇺🇸
Sacramento, CA Site, Sacramento, California, United States
🇺🇸Sarasota, FL Site, Sarasota, Florida, United States
🇺🇸Itasca, IL Site, Itasca, Illinois, United States
DaxibotulinumtoxinA for Injection for the Treatment of Plantar Fasciitis
- Conditions
- Plantar Fasciitis
- Interventions
- Biological: DAXI 80 UOther: PlaceboBiological: DAXI 120 U
- First Posted Date
- 2019-01-31
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- Revance Therapeutics, Inc.
- Target Recruit Count
- 155
- Registration Number
- NCT03825315
- Locations
- 🇺🇸
Aung Foot Health Clinic, Tucson, Arizona, United States
🇺🇸Sacramento Foot and Ankle Center, Inc, Carmichael, California, United States
🇺🇸Bay Area Foot Care, San Francisco, California, United States
Efficacy and Safety of DaxibotulinumtoxinA for Injection for the Treatment of Adult Upper Limb Spasticity
- Conditions
- Upper Limb Spasticity
- Interventions
- Biological: DAXI for injection 500 UBiological: DAXI for injection 250 UBiological: DAXI for injection 375 UOther: Placebo
- First Posted Date
- 2019-01-29
- Last Posted Date
- 2023-09-21
- Lead Sponsor
- Revance Therapeutics, Inc.
- Target Recruit Count
- 83
- Registration Number
- NCT03821402
- Locations
- 🇺🇸
Rancho Research Institute at Rancho Los Amigos National Rehab Center, Downey, California, United States
🇺🇸The Parkinsons and Movement Disorder Institute, Fountain Valley, California, United States
🇺🇸Collaborative Neuroscience Network LLC, Long Beach, California, United States
Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Forehead Lines (Frontalis)
- Conditions
- Frown Lines
- Interventions
- Biological: DaxibotulinumtoxinA for injection
- First Posted Date
- 2018-12-26
- Last Posted Date
- 2023-02-16
- Lead Sponsor
- Revance Therapeutics, Inc.
- Target Recruit Count
- 61
- Registration Number
- NCT03786770
- Locations
- 🇺🇸
Boca Raton site, Boca Raton, Florida, United States
🇺🇸Coral Gables site, Coral Gables, Florida, United States
🇨🇦Toronto, Ontario site, Toronto, Ontario, Canada
Long-Term Safety and Efficacy of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-OLS)
- Conditions
- Cervical Dystonia
- Interventions
- Biological: daxibotulinumtoxinA for injection
- First Posted Date
- 2018-08-06
- Last Posted Date
- 2022-01-28
- Lead Sponsor
- Revance Therapeutics, Inc.
- Target Recruit Count
- 357
- Registration Number
- NCT03617367
- Locations
- 🇺🇸
HOPE Research Institute, Phoenix, Arizona, United States
🇺🇸Movement Disorders Center of Arizona, Scottsdale, Arizona, United States
🇺🇸The Parkinsons and Movement Disorder Institute, Fountain Valley, California, United States
Single Treatment of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-1)
- Conditions
- Cervical Dystonia
- Interventions
- Biological: PlaceboBiological: DaxibotulinumtoxinA for injection
- First Posted Date
- 2018-08-01
- Last Posted Date
- 2022-12-05
- Lead Sponsor
- Revance Therapeutics, Inc.
- Target Recruit Count
- 301
- Registration Number
- NCT03608397
- Locations
- 🇺🇸
HOPE Research Institute, Phoenix, Arizona, United States
🇺🇸Movement Disorders Center of Arizona, Scottsdale, Arizona, United States
🇺🇸The Parkinsons and Movement Disorder Institute, Fountain Valley, California, United States
Phase 2 DaxibotulinumtoxinA for Injection for the Management of Plantar Fasciitis
- Conditions
- Plantar Fasciitis
- Interventions
- Biological: PlaceboBiological: Botulinum Toxins, Type A
- First Posted Date
- 2017-05-02
- Last Posted Date
- 2023-09-18
- Lead Sponsor
- Revance Therapeutics, Inc.
- Target Recruit Count
- 59
- Registration Number
- NCT03137407
- Locations
- 🇺🇸
Village Podiatry Centers, Duluth, Georgia, United States
🇺🇸Weil Foot and Ankle Institute, Des Plaines, Illinois, United States
🇺🇸Kansas City Bone & Joint Clinic, Overland Park, Kansas, United States